LeukemiaAdvocacy information - July 2024

Advocacy information – July 2024








Advocacy information – July 2024 – Leukaemia Basis























Thursday July 25, 2024

Uncover extra concerning the newest developments in our analysis and advocacy efforts.

  • The Leukaemia Foundation recently prepared three separate submissions supporting greater, more affordable access to three therapeutics for multiple myeloma, follicular lymphoma and acute lymphoblastic leukaemia (ALL).
  • If subsidised, these treatments may give eligible patients better access to additional treatment options.
  • These separate submissions are provided to the relevant bodies making recommendations on whether drugs/therapies are subsidised (MSAC/PBAC).
  • Without subsidy, these can be very expensive, and for some, unaffordable. Equitable, affordable access to treatment is therefore about helping to save lives, and is also about health system equity.
  • In an effort to amplify the voice of Australians living with blood cancer, these submissions include first-hand accounts and experiences from patients who have either been treated with the drug as part of a clinical trial, or had relevant experience with a similar treatment.


LEAVE A REPLY

Please enter your comment!
Please enter your name here

Subscribe Today

GET EXCLUSIVE FULL ACCESS TO PREMIUM CONTENT

SUPPORT NONPROFIT JOURNALISM

EXPERT ANALYSIS OF AND EMERGING TRENDS IN CHILD WELFARE AND JUVENILE JUSTICE

TOPICAL VIDEO WEBINARS

Get unlimited access to our EXCLUSIVE Content and our archive of subscriber stories.

Latest article

More article